Pravastatin Sodium tablets recalled for manufacturing practice violations
Accord Healthcare is recalling Pravastatin Sodium 20 mg tablets following an FDA inspection that identified manufacturing practice deviations. Approximately 32,688 bottles were distributed in the United States, Puerto Rico, and Canada.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving manufacturing practice deviations found during an FDA inspection. While no illnesses or injuries have been reported, CGMP violations represent a real quality and safety risk in a pharmaceutical product requiring mandatory action.
Plain-English summary
Accord Healthcare, Inc. is recalling Pravastatin Sodium Tablets USP 20 mg in 90-count bottles due to Current Good Manufacturing Practice (CGMP) deviations discovered during an FDA inspection. The affected product has NDC 16729-009-15 and affected batch numbers are R2200589, R2200689, R2200690, and R2201232, all with an expiration date of April 30, 2024.
Approximately 32,688 bottles have been distributed in the United States, including Puerto Rico, and Canada. The product is manufactured by Intas Pharmaceuticals Limited in Ahmedabad, India, for Accord Healthcare, Inc., of Durham, North Carolina.
The FDA classifies this recall as a Class II recall. No illnesses or injuries related to the recalled tablets have been reported as of the time of this recall notice.
Patients taking these tablets should contact their pharmacy or healthcare provider for guidance regarding their treatment. Unused tablets should be properly disposed of through a pharmacy or following FDA disposal guidelines.
The recalled product
- Product
- PRAVASTATIN SODIUM (PRAVASTATIN SODIUM)
- Brand
- PRAVASTATIN SODIUM
- Manufacturer
- Accord Healthcare, Inc.
- Category
- Drug — Oral Tablet
- Hazard
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Batches: a )R2200589
- R2200689
- R2200690
- R2201232
- Exp. Date 4/30/2024
UPCs (1)
- 316729009157
Distribution
Distribution scope not specified by the agency.
Related recalls
Same brand · PRAVASTATIN SODIUM
- ModerateFDA Recalls Pravastatin Sodium Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2025-04-16
- ModeratePravastatin Sodium Tablets Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2025-04-16
- ModerateDrug Recall: Pravastatin Sodium Due to Manufacturing Deviations
FDA (Drugs) · 2025-04-16
- ModerateFDA recalls Glenmark Pravastatin Sodium tablets for manufacturing deviations
FDA (Drugs) · 2025-04-16
- HighPravastatin Sodium Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2024-07-24
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27